GenoMethods - Biotechnology, Bioinformatics & AI in Biology

Adicet Bio’s prula-cel delivers drug-free remission in Phase 1 lupus trial

Prula-cel from Adicet Bio put more than half of lupus patients into drug-free remission in Phase 1. The therapy showed strong safety and is moving toward a pivotal trial in late 2026.

By Elena MacLeod · September 29, 2026, 12:14 PM · 4 mins read

Drug Discovery

Myositis clinical trial pipeline surges as over forty pharma companies advance new therapies

By Elena MacLeod

Biotechnology News & Analysis

Anixa hits top dose in ovarian cancer CAR T trial

By Elena MacLeod

Drug Discovery

Theravance Biopharma takes control of YUPELRI and R&D in bold buyout

By Vivian Lin

Clinical Trials & Evidence

Single CRISPR infusion slashes LDL cholesterol for a year in early trial

By Adrian Cole

IN-DEPTH REPORTING

Biotechnology News & Analysis

IASO Bio’s FUCASO shows 95.9% response in tough plasma cell neoplasm cases

FUCASO from IASO Bio hit a 95.9% response rate in heavily pretreated plasma cell neoplasm patients in China. Results show strong durability and manageable safety in real-world clinical use.

By Elena MacLeod · September 29, 2026, 8:06 AM

Clinical Trials & Evidence

Rare blood disorder reversed after CAR-T therapy in Air Force fitness challenge

September 28, 2026, 6:02 AM

Cell & Gene Therapy

GMP growth factors hit supply wall as cell and gene therapy ramps up

September 27, 2026, 11:33 PM

BIOTECHNOLOGY NEWS & ANALYSIS >

AI in Biology

AI agent spots viral DNA repeats that mirror CRISPR

A viral DNA sequence flagged by an AI agent looks strikingly like the CRISPR system. The pattern: short repeats split by longer DNA stretches.

By Adrian Cole · September 27, 2026, 9:24 PM

Drug Discovery

AI in Biology

Living drugs upend cancer treatment at Tang Prize Masters Forum

September 26, 2026, 7:14 AM

Genomics & Multiomics

Brain atlas growth stalls clinical progress without real-world testing

September 25, 2026, 5:44 PM

Biotechnology, Decoded

GenoMethods explains biotechnology from method to medicine to market, connecting scientific evidence, clinical development, companies and the technologies shaping future health.

TOP STORIES

Adicet Bio’s prula-cel delivers drug-free remission in Phase 1 lupus trial

Myositis clinical trial pipeline surges as over forty pharma companies advance new therapies

Anixa hits top dose in ovarian cancer CAR T trial

Theravance Biopharma takes control of YUPELRI and R&D in bold buyout

Single CRISPR infusion slashes LDL cholesterol for a year in early trial

IN-DEPTH REPORTING

IASO Bio’s FUCASO shows 95.9% response in tough plasma cell neoplasm cases

Rare blood disorder reversed after CAR-T therapy in Air Force fitness challenge

GMP growth factors hit supply wall as cell and gene therapy ramps up

FEATURED STORIES

Gene edited stem cell transplants shield healthy blood from targeted leukemia therapy

Precision therapies reshape the fight against glioblastoma multiforme

Pancreatic cancer survival rises as new therapies break through clinical barriers

AI agent slashes millions from clinical trial costs

Curocell pushes for fast Rimkato launch as insurance decision nears

Colossal Biosciences delays woolly mammoth comeback to 2030s

BIOTECHNOLOGY NEWS & ANALYSIS >

AI agent spots viral DNA repeats that mirror CRISPR

Ulefnersen slows ALS decline in pivotal FUS gene trial

Claude AI finds a new programmable enzyme system for gene editing

CLINICAL TRIALS & EVIDENCE >

European investors find new ground in China biotech globalization

Living drugs upend cancer treatment at Tang Prize Masters Forum

Brain atlas growth stalls clinical progress without real-world testing

Biotechnology, Decoded